Grupo Bolivar SA (SCA)

Market Closed

10 Aug, 11:55

BVC

COL$

79,860. 00

+920

+1.1654%

- Market Cap

- P/E Ratio

- Div Yield

5,072 Volume

- Eps

COL$ 78,940

Previous Close

Add Transaction

Day Range

78,940 80,220

Year Range

68,680 99,000

Want to track SCA and more in your Portfolio? 🎯

Get Started For Free

Summary

SCA closed Monday higher at COL$79,860, an increase of 1.1654% from Friday's close, completing a monthly decrease of -0.2249% or -COL$180. Over the past 12 months, SCA stock lost -8.627%.

SCA pays dividends to its shareholders, with the most recent payment made on Jul 06, 2026. The next estimated payment will be in 6 days ago on Aug 06, 2026 for a total of COL$0.82945.

The stock of the company had never split.

The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NYSE (USD).

SCA Chart

Svenska Cellulosa Aktiebolaget SCA (publ) (SCABY) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 weeks ago

Biohaven's Revenue Path: SCA And Obesity Therapies

Biohaven's pipeline progression includes Troriluzole for spinocerebellar ataxia [SCA], which has shown a 50-70% reduction in disease progression over three years. BHV-2100, a non-opioid migraine treatment, targets unmet needs in a market affecting 40 million U.S. patients and 1 billion globally. Taldefgrobep Alfa, under investigation for SMA and obesity, demonstrated subgroup-specific motor function improvements and favorable safety in Phase 3 trials.

Seekingalpha | 1 year ago

Biohaven: Positive SCA Treatment Data Leads To Q4 2024 NDA Submission Catalyst

Biohaven Ltd. reported positive results from a pivotal study using troriluzole for the treatment of patients with spinocerebellar ataxia; the Drug achieved 50% to 70% of slowing of disease progression over 3 years. With positive data on hand from the phase 3 study using troriluzole for patients with spinocerebellar ataxia, an NDA submission is planned for Q4 of 2024. Troriluzole is also being explored for patients with obsessive compulsive disorder in two phase 3 studies; Data from these studies are expected before the end of 2024 and the 1st half of 2025.

Seekingalpha | 1 year ago

Grupo Bolivar SA (SCA) FAQ

What is the stock price today?

The current price is COL$79,860.00.

On which exchange is it traded?

Grupo Bolivar SA is listed on BVC.

What is its stock symbol?

The ticker symbol is SCA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Grupo Bolivar SA ever had a stock split?

No, there has never been a stock split.

Grupo Bolivar SA Profile

Capital Markets Industry	Financials Sector	- CEO	BVC Exchange	US38747T4849 ISIN
US Country	- Employees	1 Jul 2026 Last Dividend	- Last Split	- IPO Date

This fund will allocate a significant portion—a minimum of 80%—of its total investable capital (which includes its net assets and any borrowed funds used for investment) to derivative instruments. The value and performance of these derivatives are specifically tied to an autocallable security, which in turn references an underlying asset. Importantly, the fund operates as a non-diversified investment vehicle.

Contact Information

Address: 205 Hudson Street, 7th Floor

Phone: -

Website: https://graniteshares.com/etfs/sca

Blog Affiliate Program About Terms Privacy Help Contact Us